DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

B of A Securities Initiates Coverage On Neoleukin Therapeutics with Buy Rating, Announces $18 Price Target

B of A Securities analyst Greg Harrison initiates coverage on Neoleukin Therapeutics (NASDAQ:NLTX) with a Buy rating and a $18 price target.

Benzinga · 03/16/2020 11:12

B of A Securities analyst Greg Harrison initiates coverage on Neoleukin Therapeutics (NASDAQ:NLTX) with a Buy rating and a $18 price target.